Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Early Administration of Heparin At First Medical Contact for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: a Multicenter, Prospective, Randomized, Controlled Study

NCT05329155 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.

NCT NCT05329155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05329155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Early Administration of Heparin At First Medical Contact for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: a Multicenter, Prospective, Randomized, Controlled Study
Lead sponsor
Renmin Hospital of Wuhan University
Phase
Not applicable
Overall status
Completed
Start date
July 20, 2022
Completion date
August 20, 2024
Enrollment
1,145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary pci, stemi